Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-19

Clinical Trial Update: Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating the potential pharmacokinetic interaction between vardenafil orally disintegrating tablet and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)
  • Vardenafil ODT (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED